Submission of Monitoring Agency Report for the Quarter ended September 30, 2026.

Ganesh Consumer Products Limited [Formerly Known as Ganesh Grains Limited] Trinity Tower, 83. Topsia Road (South), 3rd Floor Kolkata - 700046, West Bengal, India Phone :+91 334015 7900 / 6633 6633 Fax :+91 33 4018 7912 Email : ggl@ganeshconsumer.com Website: ganeshconsumer.com CIN: L15311WB2000PLC091315 November 03, 2026 To To BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, Plot No. C/1, G- Block Dalal Street Bandra Kurla Complex, Bandra (East) Mumbai -400001 Mumbai- 400001 Maharashtra, India Maharastra, India Scrip Code – 544528 NSE Symbol- GANESHCP SUB: MONITORING AGENCY REPORT FOR THE QUARTER ENDED SEPTEMEBR 30 ,2026 Dear Sir/Madam, Pursuant to the Regulation 32(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Regulation 41(4) of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, we are enclosing herewith Monitoring Agency Report issued by CARE Ratings Limited for the quarter ended September 30, 2026 ,in respect of utilization of the proceeds raised through issuance of equity shares by way of Initial Public Offering (“IPO”) of the Company. Kindly take the same on your record. Thanking You For Ganesh Consumer Products Limited Narendra Mishra Company Secretary and Compliance Officer Membership No. A46018 Enclosure: As stated. Registered Office – 88. Burtolla Street, Kolkata – 700007, West Bengal, India Monitoring Agency Report No. CARE/PRO/GEN/2026-27/1081 The Board of Directors Ganesh Consumer Products Limited 88 Burtolla Street, Kolkata, West Bengal, India - 700007 November 02, 2026 Dear Sir/Ma’am, Monitoring Agency Report for the quarter ended September 30, 2026 - in relation to the IPO of Ganesh Consumer Products Limited (“the Company”) We write in our capacity of Monitoring Agency for the Fresh Issue for the amount aggregating to Rs.130 crore of the Company and refer to our duties cast under 41 of the Securities & Exchange Board of India (Issue of Capital & Disclosure Requirements) Regulations. In this connection, we are enclosing the Monitoring Agency Report for the quarter ended September 30, 2026, as per aforesaid SEBI Regulations and Monitoring Agency Agreement dated August 29, 2025. Request you to kindly take the same on records. Thanking you, Yours faithfully, Ashish Kashalkar Associate Director Ashish.kashalkar@careedge.in Report of the Monitoring Agency Name of the issuer: Ganesh Consumer Products Limited For quarter ended: September 30, 2026 Name of the Monitoring Agency: CARE Ratings Limited (a) Deviation from the objects: Not Applicable (b) Range of Deviation: Not applicable Declaration: We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the objects of the issue based on the information provided by the Issuer and information obtained from sources believed by it to be accurate and reliable. The MA does not perform an audit and undertakes no independent verification of any information/ certifications/ statements it receives. This Report is not intended to create any legally binding obligations on the MA which accepts no responsibility whatsoever, for loss or damage from the use of the said information. The views and opinions expressed herein do not constitute the opinion of MA to deal with any security of the Issuer in any manner whatsoever. Nothing mentioned in this report is intended to or should be construed as creating a fiduciary relationship between the MA and any issuer or between the agency and any user of this report. The MA and its affiliates also do not act as an expert as defined under Section 2(38) of the Companies Act, 2013. The MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report pertains and may receive separate compensation for its ratings and certain credit-related analyses. We confirm that there is no conflict of interest in such relationship/interest while monitoring and reporting the utilization of the issue proceeds by the issuer, or while undertaking credit rating or other commercial transactions with the entity. We have submitted the report herewith in line with the format prescribed by SEBI, capturing our comments where applicable. There are certain sections of the report under the title “Comments of the Board of Directors”, that shall be captured by the Issuer’s Management / Audit Committee of the Board of Directors subsequent to the MA submitting their report to the issuer and before dissemination of the report through stock exchanges. These sections have not been reviewed by the MA, and the MA takes no responsibility for such comments of the issuer’s Management/Board. Signature: Name and designation of the Authorized Signatory: Ashish Kashalkar Designation of Authorized person/Signing Authority: Associate Director 1) Issuer Details: Name of the issuer : Ganesh Consumer Products Limited Name of the promoter : Purushottam Das Mimani, Manish Mimani, Madhu Mimani, Manish Mimani (HUF) and Srivaru Agro Private Limited Industry/sector to which it belongs : FMCG – Food Products - Packaged Foods 2) Issue Details Issue Period : September 22, 2025, to September 24, 2025 Type of issue (public/rights) : Public Type of specified securities : Equity shares IPO Grading, if any : Not applicable Issue size (in crore) : Rs.130 crore (Refer to Note below) Note: As per the prospectus, the company proposed to issue 40,40,457 shares (including 40,06,211 shares to public at Rs.322 and 34,246 shares to employees at Rs.292). However, pursuant to the Board Resolution dated September 25, 2025, the company finally allotted 40,39,687 shares (including 40,13,697 shares to public at Rs.322 and 25,990 shares to employees at Rs.292). The total shares allotted were 770 lower than the number of shares proposed in the prospectus. However, in value terms, the difference between the proposed and actual issue size amounted to Rs.260. 3) Details of the arrangement made to ensure the monitoring of issue proceeds: Source of information / certifications Comments of the Comments of the Particulars Reply considered by Monitoring Agency for Board of Monitoring Agency preparation of report Directors • There has been a delay in the utilization of the issue proceeds vis-à-vis the timeline disclosed in the prospectus. However, the Company has obtained approval from the Board vide its resolution dated May 22, 2026 to extend the timeline for utilization of unutilized proceeds during Fiscal 2027. • The Company has utilized an additional Rs. 0.52 crore towards General Corporate Purposes (GCP) over and above the amount specified in the Prospectus. Such utilization is in accordance with the Prospectus, which stipulates that any surplus arising from actual issue expenses being Prospectus, Bank statements lower than the estimated issue expenses of Rs. Whether all utilization is as per the disclosures in the No Management Certificate and Board 10.80 crore may be allocated towards GCP. As No Comments Offer Document? resolution against the estimated issue expenses, the Company has incurred actual issue expenses of ₹8.97 crore, resulting in a surplus that has been utilized towards GCP. • As per board resolution dated May 22, 2026, the quantum of utilization of funds towards the purposes under GCP was determined, which allowed Rs.12.00 crore towards “Strategic initiatives & growth opportunities”. During Q2FY27, the company utilized Rs.3.87 crore towards ’Strategic initiatives & growth opportunities’, resulting in cumulative utilization of Rs.12.43 crore. Though the funds have been utilized for the purposes specified in Source of information / certifications Comments of the Comments of the Particulars Reply considered by Monitoring Agency for Board of Monitoring Agency preparation of report Directors the board resolution, the quantum has exceeded the BR defined limit [Showing first 8,000 characters — download PDF for full document]